Gradient Investments’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Gradient Investments’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-800	Closed	-$1K	–	1613
2022 Q2	$1K	Hold	800	–	–	﹤0.01%	1202
2022 Q1	$1K	Hold	800	–	–	﹤0.01%	1159
2021 Q4	$1K	Hold	800	–	–	﹤0.01%	1212
2021 Q3	$1K	Hold	800	–	–	﹤0.01%	1126
2021 Q2	$1K	Hold	800	–	–	﹤0.01%	1131
2021 Q1	$2K	Hold	800	–	–	﹤0.01%	1042
2020 Q4	$1K	Hold	800	–	–	﹤0.01%	1110
2020 Q3	$1K	Hold	800	–	–	﹤0.01%	1114
2020 Q2	$1K	Hold	800	–	–	﹤0.01%	1021
2020 Q1	$1K	Hold	800	–	–	﹤0.01%	1063
2019 Q4	$1K	Hold	800	–	–	﹤0.01%	1074
2019 Q3	$1K	Hold	800	–	–	﹤0.01%	1080
2019 Q2	$1K	Hold	800	–	–	﹤0.01%	1002
2019 Q1	$1K	Buy	+800	New	+$1.22K	﹤0.01%	843

Gradient Investments's MBII Position: Q3 2022 in Review

Gradient Investments sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 800 shares — an estimated $1K sold.

Gradient Investments first reported a position in MBII in Q1 2019 and held it in 14 quarters. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Gradient Investments reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Gradient Investments sold 800 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1K.
Gradient Investments first reported a position in Marrone Bio Innovations, Inc. in Q1 2019 and held it in 14 quarters.
Gradient Investments's Marrone Bio Innovations, Inc. position peaked at $2K in Q1 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Gradient Investments's 13F filing for Q3 2022, filed 14 Oct 2022.